Skip to main content
. 2020 Sep 1;152:105469. doi: 10.1016/j.ejps.2020.105469

Table 3.

MTX concentration in the skin after administrating MTX Na by oral gavage and in the skin at the application site and 2.5 ± 0.5 cm away from the application site after applying MTX NC-MN. Data are reported as means ± S.D., n = 5.

Time (h) MTX concentration in the skin (µg/g)
MTX Oral MTX NC-MN
MN application site 2.5 ± 0.5 cm away from the MN application site
2 N/A 624.51 ± 405.97 166.32 ± 136.13
24 0.942 ± 0.59 312.70 ± 161.95 45.69 ± 24.52
72 0.172± 0.09 78.27 ± 30.02 20.12 ± 8.88